These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 3022083)
1. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension. Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Säynävälammi P; Pörsti I Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats. Waeber B; Gavras H; Gavras I; Chao P; Kohlman O; Bresnahan MR; Brunner HR; Vaughan D J Pharmacol Exp Ther; 1982 Nov; 223(2):510-5. PubMed ID: 6752375 [TBL] [Abstract][Full Text] [Related]
4. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223 [TBL] [Abstract][Full Text] [Related]
5. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure responses to enalapril in rats with one- and two-kidney DOC-NaCl hypertension. Arvola P; Nurmi AK; Säynävälammi P; Manninen V; Vapaatalo H Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):67-71. PubMed ID: 2540388 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907. Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
10. Plasma renin activity and changes in tissue angiotensin converting enzyme. Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558 [TBL] [Abstract][Full Text] [Related]
11. Effects of captopril on the development of tolerance to guanethidine. Rankin GO; Haas GJ Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat. Uhlenius N; Vuolteenaho O; Tikkanen I J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129 [TBL] [Abstract][Full Text] [Related]
14. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat]. Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423 [TBL] [Abstract][Full Text] [Related]
15. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats. Takata Y; Doyle AE J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514 [TBL] [Abstract][Full Text] [Related]
16. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension. Rasmussen S; Ibsen H; Giese J Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
19. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats. Ladipo CO; Egbe PE; Ibu JO Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324 [TBL] [Abstract][Full Text] [Related]
20. Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats. Matsushita K Tokai J Exp Clin Med; 1985 Oct; 10(5):545-9. PubMed ID: 3915608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]